Evidence map›Paper›PMID 30170543›Full record

ArticleBMC cell biology2018

Treatment of Trypanosoma cruzi with 2-bromopalmitate alters morphology, endocytosis, differentiation and infectivity.

Cassiano Martin Batista, Rafael Luis Kessler, Iriane Eger, Maurilio José Soares

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Cassiano Martin BatistaLaboratory of Cell Biology, Carlos Chagas Institute/Fiocruz-PR, 81310-020 Curitiba, Paraná, Brazil.
Rafael Luis KesslerLaboratory of Functional Genomics, Carlos Chagas Institute/Fiocruz-PR, 81310-020 Curitiba, Paraná, Brazil.
Iriane EgerDepartment of General Biology, State University of Ponta Grossa, 84010-290 Ponta Grossa, Paraná, Brazil.
Maurilio José SoaresLaboratory of Cell Biology, Carlos Chagas Institute/Fiocruz-PR, 81310-020 Curitiba, Paraná, Brazil. maurilio.soares@fiocruz.br.ORCID 0000-0001-9701-836X
Fundação Carlos Chagas · BRInstituto de Biologia Molecular do Paraná · BRUniversidade Estadual de Ponta Grossa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe palmitate analogue 2-bromopalmitate (2-BP) is a non-selective membrane tethered cysteine alkylator of many membrane-associated enzymes that in the last years emerged as a general inhibitor of protein S-palmitoylation. Palmitoylation is a post-translational protein modification that adds palmitic acid to a cysteine residue through a thioester linkage, promoting membrane localization, protein stability, regulation of enzymatic activity, and the epigenetic regulation of gene expression. Little is known on such important process in the pathogenic protozoan Trypanosoma cruzi, the etiological agent of Chagas disease.

resultsThe effect of 2-BP was analyzed on different developmental forms of Trypanosoma cruzi. The IC

conclusionOur results indicate that 2-BP inhibits key cellular processes of T. cruzi that may be regulated by palmitoylation of vital proteins and suggest a metacyclic trypomastigote unique target dependency during the parasite development.

Indexed as

AnimalsCell DifferentiationCell SurvivalChlorocebus aethiopsEndocytosisGenes, ProtozoanInhibitory Concentration 50Life Cycle StagesPalmitatesPalmitic AcidProtozoan ProteinsTrypanosoma cruziVero Cells2-bromopalmitatePalmitatesPalmitic AcidProtozoan Proteins2-BP inhibition2-BromopalmitateDifferentiationEndocytosisPalmitoylationTrypanosoma cruzi

Identifiers

PMID30170543
PMCPMC6119340
OpenAlexW2889013904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.